Soonchunhyang University Hospital
Seoul, South Korea
NCT Number: NCT04489030
Recently, the improved resolution with standard endoscopy allows the close observation of highly inflamed gastric mucosa without a magnifying view. In a previous study, the investigators established the endoscopic classification of H. pylori-infected stomach by non-magnifying standard endoscopy. One normal RAC pattern and three types of abnormal patterns were observed. Overall diagnostic accuracy for predicting H. pylori-infection was 91.6%. However, there is no comparison study predicting H. pylori-infection and precancerous gastric lesions between standard and magnifying endoscopy.
Looking for future studies?
Notify Me20 year–70 year
All sexes
Observational
Seoul, South Korea
The investigators aimed to evaluate the diagnostic efficacies of non-magnifying standard endoscopy for predicting H. pylori-infection status and precancerous gastric conditions, compared to magnifying NBI endoscopy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During endoscopy, gastric mucosal patterns would be examined by magnifying narrow-band imaging.
Time frame: 1 month
H. pylori positivity would be assessed using rapid urease test.
Time frame: 1 month
Gastric atrophy and intestinal metaplasia would be evaluated on the basis of histopathological examination (updated Sydney system).
Soonchunhyang University Hospital
Other
Magnifying Narrow-band Imaging for Diagnosis of H. Pylori and Precancerous Gastric Conditions: Comparison With Standard Endoscopy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06269380
Gastritis Chronic, Gastritis H Pylori
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05101395
Digestive System Diseases, Gastritis
Amman, Jubaiha, Jordan
View Trial DetailsNCT04769583
Gastritis H Pylori
Monastir, Tunisia
View Trial DetailsNCT07224048
Digestive System Diseases, Digestive System Neoplasms
Miami, Florida, United States
View Trial Details